Karanevich, Alex G.
Weisbrod, Luke J.
Jawdat, Omar
Barohn, Richard J.
Gajewski, Byron J.
He, Jianghua
Statland, Jeffrey M.
Funding for this research was provided by:
Mabel A. Woodyard Fellowship in Neurodegenerative Disorders
Roofe Fellowship in Neuroscience Research
NCRR and NCATS (UL1TR000001 (formerly UL1RR033179))
NCATS / Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium (U54NS092091)
Article History
Received: 26 April 2018
Accepted: 29 November 2018
First Online: 14 December 2018
Ethics approval and consent to participate
: This retrospective chart review was IRB-approved and received a waiver of consent by University of Kansas Medical Center Human Research Protection Program Institutional Review Board (IRB# STUDY00004291). Patient data was managed on secure servers at KUMC.
: Not applicable
: JS is a consultant for aTyr, Acceleron, Fulcrum, Regeneron, and Strongbridge. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.